This protocol is judged by an institutional critique board, an independent group that reviews any medical trials involving people. If a study requires a Timetable I drug, as soon as the board approves the protocol as ethical, the researchers have to make an application for an investigational new drug (IND) selection with the FDA.Some scientists an